Aurobindo Pharma (AUROPHARMA) AI stock analysis
hemvest AI's AI scores Aurobindo Pharma (AUROPHARMA) in Healthcare 60/100, a neutral reading on its 3–12 months horizon, as of 2026-11-18. The score combines technical trend, momentum, volume, breakout, fundamentals, F&O positioning, delivery and sentiment. It is research, not investment advice.
AI score 60/100 · NEUTRAL · Healthcare
Building the AI research report for AUROPHARMA…
7 research layers + breakout · live price · fundamentals · 3 horizons